Free Trial
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

Health Catalyst logo
$3.99 -0.04 (-0.99%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$4.00 +0.01 (+0.38%)
As of 07:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Health Catalyst Stock (NASDAQ:HCAT)

Key Stats

Today's Range
$3.93
$4.07
50-Day Range
$3.60
$4.52
52-Week Range
$3.49
$9.24
Volume
335,128 shs
Average Volume
611,120 shs
Market Capitalization
$277.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Moderate Buy

Company Overview

Health Catalyst Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

HCAT MarketRank™: 

Health Catalyst scored higher than 92% of companies evaluated by MarketBeat, and ranked 91st out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Health Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on 7 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Health Catalyst has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Health Catalyst's stock forecast and price target.
  • Earnings Growth

    Earnings for Health Catalyst are expected to grow in the coming year, from ($0.33) to ($0.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Health Catalyst is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Health Catalyst is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Health Catalyst has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Health Catalyst's valuation and earnings.
  • Percentage of Shares Shorted

    4.78% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Health Catalyst has recently increased by 1.57%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Health Catalyst does not currently pay a dividend.

  • Dividend Growth

    Health Catalyst does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.78% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Health Catalyst has recently increased by 1.57%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Health Catalyst has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Health Catalyst this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $45,221.00 in company stock.

  • Percentage Held by Insiders

    Only 2.60% of the stock of Health Catalyst is held by insiders.

  • Percentage Held by Institutions

    85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Health Catalyst's insider trading history.
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

HCAT Stock News Headlines

Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Target Price at $8.00
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
HCAT - Health Catalyst Inc Key Metrics - Morningstar
See More Headlines

HCAT Stock Analysis - Frequently Asked Questions

Health Catalyst's stock was trading at $7.07 at the beginning of 2025. Since then, HCAT stock has decreased by 43.6% and is now trading at $3.99.

Health Catalyst, Inc. (NASDAQ:HCAT) announced its quarterly earnings data on Wednesday, November, 6th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by $0.03. The company's revenue for the quarter was up 3.5% on a year-over-year basis.
Read the conference call transcript
.

Health Catalyst (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Health Catalyst's top institutional shareholders include Signal Advisors Wealth LLC (0.25%). Insiders that own company stock include Daniel D Burton, Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn and Duncan Gallagher.
View institutional ownership trends
.

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
11/06/2024
Today
7/10/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Computer Software
Current Symbol
NASDAQ:HCAT
CIK
1636422
Fax
N/A
Employees
1,500
Year Founded
N/A

Price Target and Rating

High Price Target
$16.00
Low Price Target
$4.00
Potential Upside/Downside
+100.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$69.50 million
Net Margins
-23.34%
Pretax Margin
-23.20%
Return on Equity
-6.14%
Return on Assets
-2.74%

Debt

Debt-to-Equity Ratio
0.40
Current Ratio
1.24
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$306.58 million
Price / Sales
0.91
Cash Flow
$0.35 per share
Price / Cash Flow
11.43
Book Value
$6.00 per share
Price / Book
0.67

Miscellaneous

Outstanding Shares
69,600,000
Free Float
67,791,000
Market Cap
$277.70 million
Optionable
Optionable
Beta
1.51
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:HCAT) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners